logo
  

Teva Pharmaceutical Industries Limited Q2 adjusted earnings Inline With Estimates

Teva Pharmaceutical Industries Limited (TEVA) released earnings for its second quarter that climbed from last year.

The company's earnings came in at $207 million, or $0.19 per share. This compares with $140 million, or $0.13 per share, in last year's second quarter.

Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $651 million or $0.59 per share for the period.

Analysts had expected the company to earn $0.59 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 1.0% to $3.91 billion from $3.87 billion last year.

Teva Pharmaceutical Industries Limited earnings at a glance:

-Earnings (Q2): $651 Mln. vs. $605 Mln. last year.
-EPS (Q2): $0.59 vs. $0.55 last year.
-Analysts Estimate: $0.59
-Revenue (Q2): $3.91 Bln vs. $3.87 Bln last year.

-Guidance:
Full year EPS guidance: $2.50 - $2.70
Full year revenue guidance: $16.0 - $16.4 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT